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One of the most common mental health conditions, generalized anxiety disorder (GAD), affects 5 
to 12 percent of the United States population.1 For those in need of treatment, standard options are to 
pursue antidepressants or psychotherapy, the latter being an appealing choice for many as it aims to 
confront the foundational issues associated with GAD and involve the sufferer on a more personal level. 
Ralph Waldo Emerson once said, “Nothing can bring you peace but yourself.” This sentiment may be 
particularly appropriate when considering people who experience GAD.  
According to the DSM-V,2 specific diagnostic criteria are required to make the diagnosis of GAD 
(see Table 1). As could be expected from examining these diagnostic criteria, GAD can have a profound 
impact on the lives of people who suffer from it. These negative effects include missed work days, 
increased sick time, increased consumption of healthcare resources,3 possible poor health outcomes, the 
potential for polypharmacy, as well as negatively-impacted social and personal relationships. Given the 
morbidity associated with GAD, treatment is desirable. Currently available therapy for GAD generally 
consists of either psychopharmacology, usually with selective serotonin reuptake inhibitors (SSRIs) or 
other antidepressants or anxiolytics such as benzodiazepines, or nonpharmacologic modalities such as 
cognitive behavioral therapy (see Table 2). 
Table 1: Diagnostic Criteria for Generalized Anxiety Disorder 
A. Excessive anxiety and worry (apprehensive expectation), occurring more days than not for at 
least 6 months, about a number of events or activities (such as work or school performance). 
B. The individual finds it difficult to control the worry. 
C. The anxiety and worry are associated with three (or more) of the following 6 symptoms (with 
at least some symptoms having been present for more days than not for the past 6 months): 
1. Restlessness or feeling keyed up or on edge. 
2. Being easily fatigued. 
3. Difficulty concentrating or mind going blank. 
4. Irritability. 
5. Muscle tension. 
6. Sleep disturbance (difficulty falling or staying asleep, or restless, unsatisfying sleep). 
D. The anxiety, worry, or physical symptoms cause clinically significant stress or impairment in 
social, occupational, or other important areas of functioning.  
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E. The disturbance is not attributable to the physiological effects of a substance (e.g., a drug of 
abuse, a medication) or another medical condition (e.g., hyperthyroidism). 
F. The disturbance is not better explained by another mental disorder (e.g., anxiety or worry 
about having panic attacks in panic disorder, negative evaluation in social anxiety [social 
phobia], contamination or other obsessions in obsessive-compulsive disorder, separation 
from attachment figures in separation anxiety disorder, reminders of traumatic events in 
posttraumatic stress disorder, gaining weight in anorexia nervosa, physical complaints in 
somatic symptom disorder, perceived appearance flaws in body dysmorphic disorder, having 
a serious illness in illness anxiety disorder, or the content of delusional beliefs in 
schizophrenia or delusional disorder). 
Source: American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, 
VA: American Psychiatric Association; 2013:222. 
Table 2: Nonpharmacologic Modalities for the Treatment of GAD 
Cognitive Behavioral Therapy (CBT)* Diet and lifestyle modifications  
Mindfulness-Cognitive Behavioral Therapy (M-
CBT) 
Complementary and Alternative Medicines 
(CAMs) 
Yoga Exercise, moderate 
*Most commonly utilized nonpharmacologic modality in GAD treatment 
Source: Roseanna Pauli, PA-S 
The adoption of nonpharmacologic modalities is an attractive option for many providers and 
patients alike because it decreases the likelihood of polypharmacy and the potential associated risks and 
adverse effects of certain medications. SSRIs and benzodiazepines can increase fall and fracture risk, 
impair cognitive processes, and benzodiazepines may additionally carry the risk of abuse or dependence.4 
Furthermore, the concept of “deprescribing” (lowering the pill burden and optimizing drug regimens) is 
gaining traction, especially in the elderly. Although not explicitly designated as diagnostic criteria, lack of 
control is often a feature of GAD that patients complain about, so self-determination of disease 
management is an important factor to consider when choosing among treatment options. Empowering 
patients by giving them a breadth of options to choose from may increase compliance and improve 
treatment outcomes.  
Since GAD is usually a life-long disorder, selecting a therapy that is both effective and safe is 
essential.  The relative safety of nonpharmacologic therapies compared to drug therapy, coupled with the 
preference to avoid medications, are factors favoring nonpharmacologic means for control of GAD.  
Whether one form of nonpharmacologic therapy is superior in efficacy to another, specifically whether 
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CBT is better in adult patients, is worth examining.  In addition, because this disorder is chronic, the 
durability of therapeutic actions is important, for which reason evidence confirming symptom control for 
at least one year’s duration is preferable. 
Discussion 
Medical literature was searched to examine whether CBT was better than other 
nonpharmacologic therapies.  Terms such as “generalized anxiety disorder,” “cognitive behavioral 
therapy,” “nonpharmacologic treatment,” and “mindfulness” were used.  Several studies were 
discovered, including two relevant randomized trials, a pilot study, and five meta-analyses.  
In the randomized controlled trial (RTC) by Wong et al, changes in anxiety levels were compared 
among 182 adults with GAD randomly assigned to Mindfulness-CBT (M-CBT), CBT-based psychotherapy, 
and usual care, which was considered unrestricted access to primary care services (no specific 
intervention).5 M-CBT was conducted weekly for 8 weeks and included homework such as breathing 
exercises. The CBT-based psychoeducation group was similarly conducted, however specific teachings 
that may have enhanced mindfulness were avoided. Active intervention participants were followed for an 
additional 6 months, with outcome measures assessed at 8- and 11-months post-baseline. Both active 
treatment arms showed significant reduction in Beck Anxiety Inventory (BAI) scores compared to the usual 
care group, but no statistical significance between the two active groups was found, which surprised the 
authors who predicted that M-CBT would be superior. Limitations of this study were its small study size, 
the lower adherence in the M-CBT group, and the lack of long-term findings for the usual care group in 
which active treatment was eventually initiated. Additionally, some patients in the MCBT, 
psychoeducation, and usual care groups were on concurrent medical therapy for anxiety, which could 
skew results. 
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In a pilot study, Khalsa et al enrolled 32 adult patients with GAD and employed yoga-enhanced 
CBT (Y-CBT) in an effort to improve treatment outcomes.6 Even though the number of patients was small, 
these patients were all formally diagnosed with GAD and had been treatment-resistant. Participants 
completed 3 sets of 6 weekly sessions and homework requesting them to practice techniques and rate 
their effects. Statistically significant improvements in anxiety were observed in these refractory patients, 
as well as improvements in comorbid symptoms of depression, panic, suicidality, sleep disturbances, 
sexual dysfunction, and poor quality of life. Important limitations of this study included its lack of ability 
to discern between the components of Y-CBT (yoga, mindfulness, CBT) and its very small sample size. 
However, evidence that previously treatment-resistant patients experienced significant improvements 
with these interventions is very encouraging.  
In a second randomized trial, which is ongoing, Brenes et al are performing a two-stage 
randomized preference trial comparing the effectiveness of CBT with yoga for improving worry in 500 
older adults with clinically significant worry, defined as “a chain of thoughts and images, negatively affect 
laden and relatively uncontrollable.”4(p169) Participants were randomized to either the preference group 
or the random group, and then participants of each group were randomized to either to CBT or yoga for 
10 weeks with 6 months follow up assessment. CBT is being conducted weekly, while yoga is being 
performed biweekly. Utilizing the generally conservative intent-to-treat analysis, how patient preference 
and choice of treatment options affected their efficacy was examined. This study was limited because 
participants were selected based on clinically significant worry rather than a formal clinical diagnosis of 
GAD. Although the results of this study are pending, the authors’ previous study on late-life GAD found 
that patients wanted more nonpharmacologic options and preferred to choose which intervention to 
undergo.7 
Several meta-analyses examined whether mindfulness-based therapy such as meditation, 
exercise, and CBT are effective in the treatment of GAD. The table below, Table 3, summarizes the meta-
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analyses, their generalized findings, and their strengths and limitations. Some pitfalls to meta-analysis 
techniques include criteria for study selection, the quality of studies, reactivity effects, and other statistical 
suppositions. Additionally, some studies have strict diagnostic criteria while others focus on clinical 
symptom improvement.  
Table 3: Meta-Analyses 
Title and Author Findings Strengths and/or 
Limitations 
The Effect of Mindfulness-Based 
Therapy on Anxiety and 
Depression: A Meta-Analytic 
Review (Hofmann et al)8 
 Mindfulness-based therapy is 
moderately effective in 
improving anxiety and mood 
symptoms 
 Good generalizability 
Complementary Medicine, 
Exercise, Meditation, Diet, and 
Lifestyle Modification for Anxiety 
Disorders: A Review of Current 
Evidence (Sarris et al)9 
 Strong support exists for 
lifestyle modifications, 
including the adoption of 
moderate exercise  
 Encouraging preliminary data 
for dietary improvements, 
including the avoidance of 
caffeine, alcohol, and nicotine 
 Tentative supportive evidence 
for acupuncture, massage, 
naturopathy (hampered by 
overall poor methodology) 
 Homeopathy is not supported 
 Kava has supportive evidence 
to reduce anxiety but risks 
include hepatotoxicity and lack 
of herbal standardization 
 Encouraging evidence to 
support mindfulness 
meditation, but insufficient 
evidence to support yoga and 
tai chi (scarce current 
research) 
 Nonsystematic 
approach to data 
inclusion 
 Only English language 
studies were included 
 Intricate written 
analysis of the data was 
not possible due to 
publication space 
restrictions 
Effect of Cognitive Behavioral 
Therapy for Anxiety Disorders on 
Quality of Life: A Meta-Analysis 
(Hofmann et al)10 
 Solid evidence for benefit of 
CBT on improved quality of life 
(moderate number of rigorous 
studies) 
 Face-to-face CBT is 
significantly better than 
internet-delivered treatments 
 Relatively small sample 
size 
 Limited generalizability 
 Different self-reported 
instruments used to 
measure the quality of 
life 
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How effective are cognitive 
behavior therapies for major 
depression and anxiety 
disorders? A meta-analytic 
update of the evidence (Cuijpers 
et al)11 
 CBT is probably effective in the 
treatment of GAD (small 
number of high-quality 
studies) 
 Effects are large when 
compared to waiting list 
control groups, but small to 
moderate when compared to 
more conservative control 
groups such as care-as-usual 
and pill placebo 
 Insignificant results 
could be due to a 
relatively small number 
of studies per disorder 
and the relatively large 
number of predictors 
Exercise as Treatment for 
Anxiety: Systematic Review and 
Analysis (Stonerock et al)12 
 The suggestion that exercise 
could be a useful, affordable, 
accessible treatment for 
anxiety (not many well-
designed RTCs) 
 At present, the existing body 
of evidence is not of sufficient 
scientific rigor to recommend 
exercise as a treatment among 
individuals with clinically 
elevated anxiety 








adherence and fitness 
levels 
Source: Roseanna Pauli, PA-S 
Most of the evidence in these meta-analyses supports CBT for treating GAD, while exercise, yoga, 
mindfulness, and lifestyle modifications may work as well.  However, more research is needed to confirm 
the validity of these studies. At this time complementary and alternative medicines (CAMs) have only 
weak support because generalizability of these studies is limited and actual ingredient identification and 
potency in CAMs are not standardized. Furthermore, nonpharmacologic modalities for GAD are not often 
compared against each other, which gap in knowledge could be filled by RTCs designed to make these 
comparisons directly.  
Conclusion 
Classic CBT is the most widely accepted, studied, and understood nonpharmacologic modality 
utilized in the treatment of GAD. It has proven to be effective. Its application is probably best face-to-face, 
but internet-based approaches are used as well. Versions of CBT augmented with yoga, mindfulness, or 
other variations are effective as well, but the differentiating and weighting of the value of the individual 
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components is difficult. Additionally, research into their applications remains limited. Lifestyle 
modifications, exercise, and CAMs have shown some potential benefits, but clinicians may be hesitant to 
recommend them because substantial evidence for their efficacy is lacking. Furthermore, the duration of 
effectiveness has not been well studied in modalities other than CBT, a common shortcoming in the 
research. Conducting more head-to-head comparisons of CBT versus pharmacotherapies, with or without 
other modalities, for the treatment of GAD would be of considerable interest and could provide insight 
into which therapies have more durability. 
Besides pharmacotherapy, CBT is the only empirically supported therapy for GAD. CBT’s ability to 
reduce acute anxiety symptoms is well accepted. Furthermore, the effects of CBT have been shown to last 
up to two years following treatment.13 Both patient preference and provider comfort play a role in the 
decision-making process of initiating various forms of therapy. While some patients may be eager to 
implement pharmacotherapy as a simpler, less demanding remedy, others may desire more self-
determination and use of holistic approaches. On the contrary, some providers may not feel comfortable 
recommending or providing CBT without additional training. Implementing either or both of these 
approaches is reasonable. Availability and access to care are crucial for the delivery of CBT, as it often 
requires extra office visits, potential co-pays, dedicated time commitments, and sufficient patient 
motivation. CBT in its many forms, or even some of the other holistic approaches that do no harm, may 
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